enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. AstraZeneca stock drops after lung cancer drug trial setback

   www.aol.com/news/astrazeneca-shares-drop-lung...

   (Reuters) -London-listed AstraZeneca shares fell more than 5% on Tuesday after results from the company's lung cancer trials showed that its experimental precision drug did not significantly ...

3. Merck-AstraZeneca breast cancer drug reduces risk of ... - AOL

   www.aol.com/finance/merck-astrazeneca-breast...

   About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo. Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients ...

4. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

5. Medicare to kick off first drug price negotiations, and it ...

   www.aol.com/news/medicare-kick-off-first-drug...

   The government is set to begin negotiating prices on the 10 costliest prescription drugs covered by Medicare this week, setting the stage for a fierce tug of war between U.S. officials and drugmakers.

6. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Four drugs from the class of direct Xa inhibitors are marketed worldwide. Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3]

7. Category:Drugs developed by AstraZeneca - Wikipedia

   en.wikipedia.org/wiki/Category:Drugs_developed...

   Pages in category "Drugs developed by AstraZeneca" The following 133 pages are in this category, out of 133 total. This list may not reflect recent changes. A.

8. Biden administration says Medicare negotiated price discounts ...

   www.aol.com/biden-administration-says-medicare...

   The list price of Merck's diabetes drug Januvia will be slashed to $113 for a 30-day supply from $527 as of 2023. Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer, will cost $231 for ...

9. Durvalumab - Wikipedia

   en.wikipedia.org/wiki/Durvalumab

   The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...